Corrections.
- Published in:
- 2014
- Publication type:
- Correction Notice
Works matching IS 03128008 AND DT 2014 AND VI 37 AND IP 5
Results: 23
1
2
Approved indication: hepatitis C.
- Published in:
- 2014
- Publication type:
- Product Review
3
Approved indication: chronic lymphocytic leukaemia.
- Published in:
- 2014
- Publication type:
- Product Review
4
Approved indication: HIV infection.
- Published in:
- 2014
- Publication type:
- Product Review
5
Approved indication: Hodgkin lymphoma, anaplastic large cell lymphoma.
- Published in:
- 2014
- Publication type:
- Product Review
6
Bupropion and serious cardiovascular adverse events.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 168
- Publication type:
- Article
7
Glycated haemoglobin.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
8
Medicine shortages information resource.
- Published in:
- 2014
- Publication type:
- Web Site Review
9
Approved indication: chronic obstructive pulmonary disease.
- Published in:
- 2014
- Publication type:
- Product Review
10
Propranolol - prescribing to patients who may be at risk of self-harm.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 169
- Publication type:
- Article
11
Dental note.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 167, doi. 10.18773/austprescr.2014.067
- By:
- Publication type:
- Article
12
Stockley's Drug Interactions, Pocket Companion.
- Published in:
- 2014
- By:
- Publication type:
- Book Review
13
Valproate - fetal exposure and cognitive impairment.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 170
- Publication type:
- Article
14
Janus kinase inhibitors in myeloproliferative neoplasms.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 161, doi. 10.18773/austprescr.2014.063
- By:
- Publication type:
- Article
15
Methylphenidate and priapism.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 169
- Publication type:
- Article
16
Differences in Australian and New Zealand medicines funding policies.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 150, doi. 10.18773/austprescr.2014.059
- By:
- Publication type:
- Article
17
The Pharmacy Guild perspective.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 146, doi. 10.18773/austprescr.2014.057
- By:
- Publication type:
- Article
18
Tricks of the trade in drug promotion.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 163, doi. 10.18773/austprescr.2014.060
- By:
- Publication type:
- Article
19
Janus kinase inhibitors in rheumatoid arthritis.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 158, doi. 10.18773/austprescr.2014.062
- By:
- Publication type:
- Article
20
Mechanisms of action.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 154
- By:
- Publication type:
- Article
21
The 'polypill'.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
22
Intravenous paracetamol in paediatrics: cause for concern.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
23
A health policy perspective.
- Published in:
- Australian Prescriber, 2014, v. 37, n. 5, p. 148, doi. 10.18773/austprescr.2014.058
- By:
- Publication type:
- Article